{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "antigen",
      "automation",
      "diagnosis",
      "nasopharyngeal swab"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34331847",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1515/cclm-2021-0569"
    ],
    "Journal": {
      "ISSN": "1437-4331",
      "JournalIssue": {
        "Volume": "59",
        "Issue": "12",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov",
          "Day": "25"
        }
      },
      "Title": "Clinical chemistry and laboratory medicine",
      "ISOAbbreviation": "Clin Chem Lab Med"
    },
    "ArticleTitle": "Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs.",
    "Pagination": {
      "StartPage": "2003",
      "EndPage": "2009",
      "MedlinePgn": "2003-2009"
    },
    "Abstract": {
      "AbstractText": [
        "The detection of SARS-CoV-2 in infected people is a key tool to help in controlling COVID-19 pandemic. Like rapid antigenic tests, automated antigen tests, that present the advantage of a higher throughput flow, may be of interest. The LIAISON<sup>\u00ae</sup> SARS-CoV-2 Ag test was evaluated for the quantification of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs by comparison to RT-PCR.",
        "The study involved 378 nasopharyngeal samples (UTM<sup>\u00ae</sup> and FLOQSwab\u2122, Copan Diagnostics), including 46 swabs positive for SARS-CoV-2 by RT-PCR. These samples came from asymptomatic (n=99, 26.2%) or symptomatic people (n=279, 73.8%), at different times from symptom onset. The samples were analyzed on LIAISON<sup>\u00ae</sup> XL.",
        "The overall specificity was 99.4% (CI95% [98.6-100]). The negative predictive value reached 100% in asymptomatic people. Among the 46 positive samples, the overall sensitivity was 84.8% (CI95% [74.4-95.2]), reached 91.9% (CI95% [83.1-100]) in the first fourth days after symptoms onset and was 100% for Cq values\u00a0\u226425. Antigen was not detected in samples with Cq values >25. Similar results were observed on nasopharyngeal swabs coming from patients infected with the 20I/501Y.V1 variant or the 20H/501Y.V2 variant.",
        "According to technical performances, the LIAISON<sup>\u00ae</sup> SARS-CoV-2 Ag test may be a useful tool for COVID-19 diagnosis, especially during the first four days of symptoms."
      ],
      "CopyrightInformation": "\u00a9 2021 Walter de Gruyter GmbH, Berlin/Boston."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Lorraine, CNRS, LCPME, Nancy, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Laboratoire de Virologie, CHRU de Nancy Brabois, Vandoeuvre-l\u00e8s-Nancy, France."
          }
        ],
        "LastName": "Hartard",
        "ForeName": "C\u00e9dric",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Plateforme de G\u00e9nomique Microbienne, CHRU de Nancy Brabois, Vandoeuvre-l\u00e8s-Nancy, France."
          }
        ],
        "LastName": "Berger",
        "ForeName": "Sibel",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Plateforme de G\u00e9nomique Microbienne, CHRU de Nancy Brabois, Vandoeuvre-l\u00e8s-Nancy, France."
          }
        ],
        "LastName": "Josse",
        "ForeName": "Thomas",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Lorraine, CNRS, LCPME, Nancy, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Laboratoire de Virologie, CHRU de Nancy Brabois, Vandoeuvre-l\u00e8s-Nancy, France."
          }
        ],
        "LastName": "Schvoerer",
        "ForeName": "Evelyne",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Lorraine, CNRS, LCPME, Nancy, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Laboratoire de Virologie, CHRU de Nancy Brabois, Vandoeuvre-l\u00e8s-Nancy, France."
          }
        ],
        "LastName": "Jeulin",
        "ForeName": "H\u00e9l\u00e8ne",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Evaluation Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Clin Chem Lab Med",
    "NlmUniqueID": "9806306",
    "ISSNLinking": "1434-6621"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Reagent Kits, Diagnostic"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Area Under Curve"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Automation"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Nasopharynx"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Nucleocapsid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "ROC Curve"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reagent Kits, Diagnostic"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}